These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11913569)

  • 1. Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid.
    Serdaroglu G; Tütüncüoglu S; Kavakli K; Tekgül H
    J Child Neurol; 2002 Jan; 17(1):41-3. PubMed ID: 11913569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired von Willebrand syndrome as side effect of valproic acid therapy in children is rare.
    Eberl W; Budde U; Bentele K; Christen HJ; Knapp R; Mey A; Schneppenheim R
    Hamostaseologie; 2009 May; 29(2):137-42. PubMed ID: 19404518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-associated coagulopathies are frequent and variable in children.
    Gerstner T; Teich M; Bell N; Longin E; Dempfle CE; Brand J; König S
    Epilepsia; 2006 Jul; 47(7):1136-43. PubMed ID: 16886976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfatide-binding assay for von Willebrand factor. Detection of von Willebrand's disease without discrimination of vWD subtypes.
    Favaloro EJ
    Thromb Res; 2000 Apr; 98(2):213-9. PubMed ID: 10713323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the "neutral" monoclonal antibody binding assay.
    Scott JP; Montgomery RR
    Am J Clin Pathol; 1991 Dec; 96(6):723-8. PubMed ID: 1746488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
    d'Alessio P; Zwaginga JJ; de Boer HC; Federici AB; Rodeghiero F; Castaman G; Mariani G; Mannucci PM; de Groot PG; Sixma JJ
    Thromb Haemost; 1990 Oct; 64(2):227-31. PubMed ID: 2125373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of von Willebrand's disease].
    Böttcher D; Hasler K; Winckelmann G; Sutor AH; Mair D
    Med Klin; 1978 Jun; 73(22):833-8. PubMed ID: 307108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
    Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
    Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of plasmas from patients previously diagnosed as having von Willebrand's disease with the factor VIII-related antigen and ristocetin cofactor assay.
    Ness PM; Hymas PG; Perkins HA
    Am J Clin Pathol; 1979 Jan; 71(1):26-30. PubMed ID: 311154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate therapy induces von Willebrand disease type I.
    Kreuz W; Linde R; Funk M; Meyer-Schrod R; Föll E; Nowak-Göttl U; Jacobi G; Vigh Z; Scharrer I
    Epilepsia; 1992; 33(1):178-84. PubMed ID: 1733754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of von Willebrand's disease revisited.
    Bowie EJ; Fass DN; Olson JD; Owen CA
    Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-type von Willebrand's disease.
    Miller JL
    Clin Lab Med; 1984 Jun; 4(2):319-31. PubMed ID: 6437734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis.
    Zighetti ML; Fontana G; Lussana F; Chiesa V; Vignoli A; Canevini MP; Cattaneo M
    Epilepsia; 2015 May; 56(5):e49-52. PubMed ID: 25757394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The platelet aggregation in children with epilepsy receiving valproic acid.
    Tanindi S; Akin R; Koseoglu V; Kurekci AE; Gokcay E; Ozcan O
    Thromb Res; 1996 Feb; 81(4):471-6. PubMed ID: 8907296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid-induced pancreatitis in childhood epilepsy: case series and review.
    Sinclair DB; Berg M; Breault R
    J Child Neurol; 2004 Jul; 19(7):498-502. PubMed ID: 15526953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.